Genetic causal role of body mass index in multiple neurological diseases.

Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE

Original Publication: London : Nature Publishing Group, copyright 2011-

Amyotrophic Lateral Sclerosis*/genetics ; Nervous System Diseases*/genetics ; Parkinson Disease*/genetics ; Multiple Sclerosis*/genetics ; Alzheimer Disease*/genetics ; Ischemic Stroke*; Humans ; Body Mass Index ; Genome-Wide Association Study ; Mendelian Randomization Analysis ; Obesity/genetics

Body mass index (BMI) is a crucial health indicator for obesity. With the progression of socio-economic status and alterations in lifestyle, an increasing number of global populations are at risk of obesity. Given the complexity and severity of neurological diseases, early identification of risk factors is vital for the diagnosis and prognosis of such diseases. In this study, we employed Mendelian randomization (MR) analysis utilizing the most comprehensive genome-wide association study (GWAS) data to date. We selected single nucleotide polymorphisms (SNPs) that are unaffected by confounding factors and reverse causality as instrumental variables. These variables were used to evaluate the genetic and causal relationships between Body Mass Index (BMI) and various neurological diseases, including Parkinson's Disease (PD), Alzheimer's Disease (AD), Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), Ischemic Stroke (IS), and Epilepsy (EP). The Inverse Variance Weighted (IVW) analysis indicated that there was no significant causal relationship between Body Mass Index (BMI) indicators and PD (P-value = 0.511), AD (P-value = 0.076), ALS (P-value = 0.641), EP (P-value = 0.380). However, a causal relationship was found between BMI indicators and MS (P-value = 0.035), and IS (P-value = 0.000), with the BMI index positively correlated with the risk of both diseases. The Cochran's Q test for MR-IVW showed no heterogeneity in the MR analysis results between the BMI index and the neurological diseases (P > 0.05). The Egger intercept test for pleiotropy revealed no horizontal pleiotropy detected in any of the neurological diseases studied (P > 0.05). It was found that there was no causal relationship between BMI and PD, AD, ALS, EP, and a genetic causal association with MS, and IS. Meanwhile, the increase in BMI can lead to a higher risk of MS and IS, which reveals the critical role of obesity as a risk factor for specific neurological diseases in the pathogenesis of the diseases.
(© 2024. The Author(s).)

Handb Clin Neurol. 2016;138:225-38. (PMID: 27637961)
Annu Rev Immunol. 2011;29:415-45. (PMID: 21219177)
J Neural Transm Suppl. 2006;(70):9-15. (PMID: 17017502)
Amyotroph Lateral Scler Frontotemporal Degener. 2013 Apr;14(3):205-11. (PMID: 23134505)
Clin Exp Immunol. 2022 Jun 23;208(3):372-379. (PMID: 35511827)
PLoS Med. 2017 Jun 13;14(6):e1002314. (PMID: 28609445)
JAMA. 2013 Jan 2;309(1):71-82. (PMID: 23280227)
Biol Psychiatry. 2022 Mar 1;91(5):498-507. (PMID: 34364650)
Stroke. 2015 Jun;46(6):1690-2. (PMID: 25944320)
PLoS One. 2015 Jun 29;10(6):e0131778. (PMID: 26121579)
Arthritis Care Res (Hoboken). 2017 Feb;69(2):157-165. (PMID: 27159376)
Neuron. 2023 Apr 5;111(7):1086-1093.e2. (PMID: 36669485)
Acta Neurol Belg. 2022 Dec;122(6):1447-1456. (PMID: 36171477)
Nat Rev Dis Primers. 2017 Oct 05;3:17071. (PMID: 28980624)
J Parkinsons Dis. 2021;11(1):31-43. (PMID: 33361610)
Eur J Epidemiol. 2017 May;32(5):377-389. (PMID: 28527048)
BMC Med. 2021 Dec 15;19(1):320. (PMID: 34906131)
Annu Rev Genomics Hum Genet. 2015;16:327-50. (PMID: 25939054)
Lancet. 2024 Jan 20;403(10423):283-292. (PMID: 38245248)
Neuroepidemiology. 2003 Sep-Oct;22(5):305-10. (PMID: 12902626)
EBioMedicine. 2018 Feb;28:21-30. (PMID: 29396300)
Folia Neuropathol. 2021;59(4):378-385. (PMID: 35114778)
Neuroepidemiology. 2021;55(3):245-252. (PMID: 34010836)
Lancet. 2008 Oct 25;372(9648):1502-17. (PMID: 18970977)
Mov Disord. 2020 Jan;35(1):55-74. (PMID: 31483535)
Stroke. 2021 Jun;52(6):2043-2052. (PMID: 33980044)
Exp Parasitol. 2016 Jan;160:54-9. (PMID: 26688099)
Stroke. 2021 Jan;52(1):144-151. (PMID: 33272129)
Mov Disord. 2022 Nov;37(11):2173-2183. (PMID: 36056888)
Circ J. 2017 Jun 23;81(7):920-928. (PMID: 28603178)
Lancet Neurol. 2019 Dec;18(12):1091-1102. (PMID: 31701892)
Epileptic Disord. 2014 Sep;16(3):343-53. (PMID: 25179745)
Drugs. 2023 Feb;83(2):135-158. (PMID: 36696027)
Wis Med J. 1988 Feb;87(2):16-8. (PMID: 3279711)
PLoS Med. 2014 Dec 09;11(12):e1001765. (PMID: 25490400)
Clin Neurol Neurosurg. 2022 Jul;218:107306. (PMID: 35636382)
Lancet Neurol. 2016 Nov;15(12):1257-1272. (PMID: 27751556)
Seizure. 2020 Oct;81:167-174. (PMID: 32827980)
Cell Rep. 2020 Oct 27;33(4):108323. (PMID: 33113361)
Front Neurosci. 2019 Oct 10;13:1084. (PMID: 31649504)
J Alzheimers Dis. 2011;26(3):495-505. (PMID: 21694454)
J Alzheimers Dis. 2021;82(2):503-512. (PMID: 34057091)
Am J Epidemiol. 2017 Mar 1;185(5):362-371. (PMID: 28158443)
J Diabetes Investig. 2019 May;10(3):780-792. (PMID: 30220102)
Psychopharmacology (Berl). 2017 May;234(9-10):1395-1418. (PMID: 28265714)
Prev Med. 2017 Mar;96:118-123. (PMID: 28040517)
Int J Obes (Lond). 2005 Jan;29(1):1-8. (PMID: 15278104)
Ann Neurol. 2001 Dec;50(6):780-6. (PMID: 11761476)
Nat Genet. 2022 May;54(5):581-592. (PMID: 35534559)
N Engl J Med. 2016 Aug 25;375(8):794-8. (PMID: 27557308)
J Pediatr. 2016 Oct;177:255-261.e2. (PMID: 27496270)
Mult Scler. 2022 Oct;28(11):1673-1684. (PMID: 35575213)
Nutrients. 2020 Mar 16;12(3):. (PMID: 32188044)
Nat Genet. 2018 May;50(5):693-698. (PMID: 29686387)
Ann Neurol. 2003 Aug;54(2):170-5. (PMID: 12891669)
Epilepsia. 2010 May;51(5):853-61. (PMID: 20067511)
Am J Med. 2021 Dec;134(12):1457-1464. (PMID: 34454905)
Methods Mol Biol. 2017;1666:581-628. (PMID: 28980266)
Curr Neurol Neurosci Rep. 2020 May 26;20(7):24. (PMID: 32458308)
Alzheimers Dement. 2014 Jun;10(3 Suppl):S122-45. (PMID: 24924665)
Epilepsy Behav. 2008 Aug;13(2):307-15. (PMID: 18490199)
J Stroke Cerebrovasc Dis. 2022 May;31(5):106380. (PMID: 35193029)
Epilepsia Open. 2023 Jun;8(2):456-465. (PMID: 36808903)
Int J Mol Sci. 2022 Aug 19;23(16):. (PMID: 36012603)
Int Tinnitus J. 2019 Sep 04;23(2):79-85. (PMID: 32009339)
Nat Commun. 2018 Dec 10;9(1):5269. (PMID: 30531953)
Cell Commun Signal. 2009 Dec 23;7:27. (PMID: 20030801)
Stat Med. 2008 Apr 15;27(8):1133-63. (PMID: 17886233)
Neurology. 2009 Sep 1;73(9):658-64. (PMID: 19474413)
JAMA Netw Open. 2021 Dec 1;4(12):e2138801. (PMID: 34910152)
Int J Epidemiol. 2011 Aug;40(4):985-96. (PMID: 21357186)
Nutrients. 2021 Sep 13;13(9):. (PMID: 34579056)
Ital J Neurol Sci. 1983 Sep;4(3):275-84. (PMID: 6358122)
Obes Facts. 2014;7(5):322-8. (PMID: 25485991)
Epileptic Disord. 2005 Sep;7 Suppl 1:S27-33. (PMID: 16120491)
Alzheimers Dement. 2018 Sep;14(9):1171-1183. (PMID: 29907423)
Epilepsia. 2010 Nov;51(11):2254-9. (PMID: 21175601)
PLoS Med. 2016 Jun 28;13(6):e1002053. (PMID: 27351487)
Int J Endocrinol. 2014;2014:203930. (PMID: 24672544)
Int J Obes (Lond). 2011 Feb;35(2):300-8. (PMID: 20714329)
Neurosurg Focus. 2009 Aug;27(2):E4. (PMID: 19645560)
JAMA. 2021 Sep 14;326(10):926-939. (PMID: 34519802)
Cell Metab. 2019 Feb 5;29(2):488-500.e2. (PMID: 30318341)
JAMA Neurol. 2016 Mar;73(3):321-8. (PMID: 26751506)
Cold Spring Harb Perspect Med. 2022 May 17;12(4):. (PMID: 34872952)
J Transl Med. 2022 Sep 9;20(1):417. (PMID: 36085169)
Nat Rev Microbiol. 2023 Jan;21(1):51-64. (PMID: 35931816)
Obesity (Silver Spring). 2015 Apr;23(4):879-85. (PMID: 25755157)
Int J Epidemiol. 2016 Dec 1;45(6):1961-1974. (PMID: 27616674)
Drugs Aging. 2021 Apr;38(4):285-299. (PMID: 33619704)
Nat Genet. 2019 Mar;51(3):414-430. (PMID: 30820047)
Science. 2019 Sep 27;365(6460):. (PMID: 31604244)
Trends Neurosci. 2007 May;30(5):194-202. (PMID: 17408759)
Lancet. 2011 Mar 12;377(9769):942-55. (PMID: 21296405)
Transl Stroke Res. 2019 Dec;10(6):639-649. (PMID: 30980283)
Transl Stroke Res. 2022 Aug;13(4):528-532. (PMID: 35013977)
J Mol Neurosci. 2013 Oct;51(2):364-70. (PMID: 23504255)
Brain. 2021 Aug 17;144(7):2214-2226. (PMID: 33787890)
J Am Soc Nephrol. 2016 Nov;27(11):3253-3265. (PMID: 27486138)
Metabolism. 2019 Mar;92:98-107. (PMID: 30399375)
Curr Top Med Chem. 2005;5(1):59-67. (PMID: 15638778)
Circ Res. 2022 Feb 18;130(4):512-528. (PMID: 35175851)
J Am Med Dir Assoc. 2022 Oct;23(10):1719.e1-1719.e7. (PMID: 36007544)
Pediatrics. 2001 Jan;107(1):E13. (PMID: 11134477)
Biomed Pharmacother. 2023 Nov;167:115503. (PMID: 37729728)
Front Aging Neurosci. 2022 Jul 11;14:919059. (PMID: 35898325)
Biochim Biophys Acta Mol Basis Dis. 2017 May;1863(5):1037-1045. (PMID: 27156888)
Am J Physiol Lung Cell Mol Physiol. 2018 Jul 1;315(1):L78-L86. (PMID: 29565180)
Folia Neuropathol. 2013;51(1):1-9. (PMID: 23553131)
PLoS Genet. 2022 Jul 7;18(7):e1010247. (PMID: 35797272)
Isr Med Assoc J. 2019 Jul;21(7):438-443. (PMID: 31507117)
Front Neurol. 2022 Oct 26;13:984824. (PMID: 36388204)
Front Neurol. 2019 May 24;10:543. (PMID: 31178821)
J Parkinsons Dis. 2022;12(1):267-282. (PMID: 34633332)
J Clin Endocrinol Metab. 2017 Jul 1;102(7):2310-2320. (PMID: 28609829)
Int Rev Neurobiol. 2019;147:45-74. (PMID: 31607362)
Neurology. 2019 Jul 30;93(5):189-191. (PMID: 31243070)
Nat Genet. 2018 Apr;50(4):524-537. (PMID: 29531354)
Arch Neurol. 2007 Mar;64(3):392-8. (PMID: 17353383)
Acta Neuropathol. 2016 Feb;131(2):211-234. (PMID: 26423537)
Indian J Pediatr. 2021 Oct;88(10):1025-1032. (PMID: 33063276)
Int J Epidemiol. 2020 Aug 1;49(4):1147-1158. (PMID: 31369124)
Lancet Neurol. 2021 Oct;20(10):795-820. (PMID: 34487721)
JAMA Neurol. 2017 Jun 1;74(6):695-703. (PMID: 28395017)
Epilepsia. 2011 Jun;52(6):1052-7. (PMID: 21449936)

82274493 National Natural Science Foundation of China; 81874389 National Natural Science Foundation of China

Keywords: BMI; IS; MS; Mendelian randomization analysis; Neurological diseases

Date Created: 20240328 Date Completed: 20240329 Latest Revision: 20240330

20240330

PMC10973473

10.1038/s41598-024-57260-2

38538647